These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12625779)
1. Oncoproteomics: state-of-the-art. Jain KK Technol Cancer Res Treat; 2002 Aug; 1(4):219-20. PubMed ID: 12625779 [TBL] [Abstract][Full Text] [Related]
2. Oncoproteomics: Trials and tribulations. Zhou L; Li Q; Wang J; Huang C; Nice EC Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147 [TBL] [Abstract][Full Text] [Related]
3. Contributions of proteome profiling to the molecular analysis of cancer. Wang H; Hanash SM Technol Cancer Res Treat; 2002 Aug; 1(4):237-46. PubMed ID: 12625782 [TBL] [Abstract][Full Text] [Related]
4. [Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology]. Espejel F; Roa JC Med Clin (Barc); 2008 Sep; 131(8):312-7. PubMed ID: 18803927 [TBL] [Abstract][Full Text] [Related]
5. Contribution of oncoproteomics to cancer biomarker discovery. Cho WC Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558 [TBL] [Abstract][Full Text] [Related]
6. Role of oncoproteomics in the personalized management of cancer. Jain KK Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798 [TBL] [Abstract][Full Text] [Related]
7. Bioinformatics for cancer management in the post-genome era. Katoh M; Katoh M Technol Cancer Res Treat; 2006 Apr; 5(2):169-75. PubMed ID: 16551136 [TBL] [Abstract][Full Text] [Related]
9. An introduction into proteomics and its clinical applications. Ahram M Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467 [TBL] [Abstract][Full Text] [Related]
10. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE). Hariharan D; Weeks ME; Crnogorac-Jurcevic T Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264 [TBL] [Abstract][Full Text] [Related]
11. Clinical proteomics for cancer biomarker discovery and therapeutic targeting. Krieg RC; Paweletz CP; Liotta LA; Petricoin EF Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785 [TBL] [Abstract][Full Text] [Related]
12. From genomics to proteomics: techniques and applications in cancer research. Martin DB; Nelson PS Trends Cell Biol; 2001 Nov; 11(11):S60-5. PubMed ID: 11684444 [TBL] [Abstract][Full Text] [Related]
13. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530 [TBL] [Abstract][Full Text] [Related]
14. Oncoproteomics: current trends and future perspectives. Cho WC; Cheng CH Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924 [TBL] [Abstract][Full Text] [Related]
18. New approaches towards integrated proteomic databases and depositories. Rohlff C Expert Rev Proteomics; 2004 Oct; 1(3):267-74. PubMed ID: 15966823 [TBL] [Abstract][Full Text] [Related]
19. Cancer: a proteomic disease. Li G; Xiao Z; Liu J; Li C; Li F; Chen Z Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689 [TBL] [Abstract][Full Text] [Related]
20. Proteomics in cancer research: Are we ready for clinical practice? Maes E; Mertens I; Valkenborg D; Pauwels P; Rolfo C; Baggerman G Crit Rev Oncol Hematol; 2015 Dec; 96(3):437-48. PubMed ID: 26277237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]